Market closed
Soligenix Inc./$SNGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
Ticker
$SNGX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
15
Website
Soligenix Inc. Metrics
BasicAdvanced
$6.2M
-
-$4.98
2.03
-
Price and volume
Market cap
$6.2M
Beta
2.03
52-week high
$2.41
52-week low
$1.68
Average daily volume
137K
Financial strength
Current ratio
1.821
Quick ratio
1.613
Total debt to equity
36.054
Interest coverage (TTM)
-48.91%
Management effectiveness
Return on assets (TTM)
-62.88%
Return on equity (TTM)
-248.97%
Valuation
Price to revenue (TTM)
27.263
Price to book
1.2
Price to tangible book (TTM)
1.2
Price to free cash flow (TTM)
-0.387
Growth
Revenue change (TTM)
-85.78%
Earnings per share change (TTM)
-60.68%
3-year revenue growth (CAGR)
-47.49%
3-year earnings per share growth (CAGR)
-59.52%
Soligenix Inc. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Soligenix Inc. stock?
Soligenix Inc. (SNGX) has a market cap of $6.2M as of April 16, 2025.
What is the P/E ratio for Soligenix Inc. stock?
The price to earnings (P/E) ratio for Soligenix Inc. (SNGX) stock is 0 as of April 16, 2025.
Does Soligenix Inc. stock pay dividends?
No, Soligenix Inc. (SNGX) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Soligenix Inc. dividend payment date?
Soligenix Inc. (SNGX) stock does not pay dividends to its shareholders.
What is the beta indicator for Soligenix Inc.?
Soligenix Inc. (SNGX) has a beta rating of 2.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.